El Salvador vs Kazakhstan: Tuberculosis treatment success rate by type
El Salvador
90
in 2023
Kazakhstan
90
in 2023
El Salvador rank
44th
Kazakhstan rank
44th
Tuberculosis treatment success rate by type over time
- El Salvador
- Kazakhstan
How they compare
El Salvador currently reports 90 against 90 in Kazakhstan, a difference of 0.
The two have swapped places 6 times across 27 shared years of data; in 1997 it was Kazakhstan ahead.
El Salvador ranks 44th and Kazakhstan ranks 44th of 194 countries.
Across the 4 decades both report, El Salvador averaged higher in 2 and Kazakhstan in 2.
Head to head by decade
| Decade | El Salvador | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 74.67 | 77.33 | 2.67 | Kazakhstan |
| 2000s | 89.2 | 80.2 | 9 | El Salvador |
| 2010s | 91.5 | 86.7 | 4.8 | El Salvador |
| 2020s | 88.25 | 89.25 | 1 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, El Salvador or Kazakhstan?
- El Salvador, at 90 against 90 in Kazakhstan as of 2023.
- What is the difference in tuberculosis treatment success rate by type between El Salvador and Kazakhstan?
- 0, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Kazakhstan?
- 27 years are reported by both, from 1997 to 2023.
- How do El Salvador and Kazakhstan rank globally for tuberculosis treatment success rate by type?
- El Salvador ranks 44th and Kazakhstan ranks 44th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.